Ian Haydock
Editor In Chief, Pharma, APAC
Japan
35+ years of experience
Datamonitor Healthcare
By Ian Haydock 15 Jun 2022
Listen to this insightful presentation of the unique challenges and opportunities faced by Japan Pharma, hosted by the expert analysts from Pharma Intelligence.
Scrip
By Ian Haydock 28 Nov 2021
In this week's podcast edition of Five Must-Know Things: the prospects and plans for J&J’s pharma and oncology business; China looks more inward under new policies; an important US approval for Takeda; and Moderna’s co-founder shares tips on innovation.
Scrip
By Ian Haydock 01 Nov 2021
In this week's podcast edition of Five Must-Know Things: Lilly goes head-to-head in Alzheimer’s; Roche eyes new opportunities for Lucentis; Novartis doubles down on innovation; BMS seeks growth amid generic threats; and the new head of Boehringer Ingelheim India talks to Scrip.
Scrip
By Ian Haydock 04 Oct 2021
In this week's podcast edition of Five Must-Know Things: the prospects for Merck’s Acceleron acquisition; the pandemic and biotech capital in-flow; an interview with Menarini’s CEO; upcoming endocrine and metabolic product disorders; and an interview with Novartis Pharma’s president.
Scrip
By Ian Haydock 16 Aug 2021
In this week's podcast edition of Five Must-Know Things: a history of Alzheimer’s drug development; BioNTech looks beyond COVID-19 vaccines; gene therapy setbacks for bluebird; new promise for Roche’s Polivy in B-cell lymphoma; and rising US momentum for US drug price negotiations.
Scrip
By Ian Haydock 27 Jun 2021
In this week's podcast edition of Five Must-Know Things: a look at pharma CEO pay; Pfizer’s CEO gives the inside track on COVID vaccine development; GSK elaborates on its restructuring and strategic plans; and Kite talks about its cell therapy plans under Gilead.
Scrip
By Ian Haydock 23 May 2021
In this week's podcast episode of Five Must-Know Things, hear about GSK coming under pressure from investors; BMS focusing on a promising oncology target in a new deal; Sanofi’s COVID-19 vaccine challenges; China's progress with mRNA coronavirus vaccines; and new headwinds for Pfizer’s Ibrance.
Scrip
By Ian Haydock 20 Apr 2021
In this week's podcast version of Five Must-Know Things, hear about adenovirus vaccines and blood clots, Lilly’s new moves in genetic diseases, the efficacy debate over Chinese COVID-19 vaccines, putting a price tag on innovation, and Sanofi’s bullishness on IL-2.
Scrip
By Ian Haydock 21 Mar 2021
In this week's podcast version of Five Must-Know Things, hear about new results for Lilly in Alzheimer’s, a US delay for AbbVie, progress for Zolgensma in the UK, challenges for AstraZeneca’s coronavirus vaccine, and a Scrip roundtable on industry lessons from the pandemic.
Scrip
By Ian Haydock 15 Mar 2021
In this week's podcast version of Five Must-Know Things, hear about Roche's deal-making in a pandemic, coronavirus vaccine disinformation, Amgen’s Five Prime acquisition, a Novartis clinical trial failure, and new data for a Merck antiviral for the coronavirus.
Scrip
By Ian Haydock 22 Feb 2021
A resolution in a long-running patent dispute, expansion of coronavirus vaccine production, drug development trends over the past decade, hematological malignancies in a clinical trial, and the last instalment in the Scrip Asks series all feature in this week's podcast version of Scrip's Five Must-Know Things.
Topic BioPharmaceutical
Scrip
By Ian Haydock 29 Nov 2020
Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things
Scrip
By Ian Haydock 27 Nov 2020
As part of broader efforts to pursue novel approaches to common neurological disorders, Eisai uses iPSC-derived cells to help identify potential new drug therapies for Parkinson's.
Topic Parkinson's Disease
Scrip
By Ian Haydock 17 Nov 2020
Take a brief audio tour around the main biopharma industry events of the past week, as brought to you by Scrip's global team, in this podcast version of Five Must-Know Things.
Topic Coronavirus M A
Scrip
By Ian Haydock 17 Nov 2020
Join us for a quick audio roundup of major developments in the international biopharma industry over the past week, as covered by Scrip's global team.
Topic Sales Earnings
Scrip
11 May 2022
Scrip
08 Mar 2022
Scrip
22 Dec 2021
Scrip
21 Dec 2021
Scrip
03 Dec 2021
Pink Sheet
30 Nov 2021
Scrip
18 Nov 2021
Scrip
15 Nov 2021
Scrip
02 Nov 2021
Pink Sheet
04 Oct 2021
Scrip
30 Sep 2021
Scrip
01 Jun 2021
Scrip
06 May 2021
Scrip
12 Apr 2021
Scrip
07 Apr 2021